BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37623489)

  • 1. Copy Number Variations and Gene Mutations Identified by Multiplex Ligation-Dependent Probe Amplification in Romanian Chronic Lymphocytic Leukemia Patients.
    Balla B; Tripon F; Candea M; Banescu C
    J Pers Med; 2023 Aug; 13(8):. PubMed ID: 37623489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression.
    Srinivasan VK; Naseem S; Varma N; Lad DP; Malhotra P
    Blood Res; 2020 Sep; 55(3):131-138. PubMed ID: 32747613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH).
    Alhourani E; Rincic M; Othman MA; Pohle B; Schlie C; Glaser A; Liehr T
    Mol Cytogenet; 2014; 7(1):79. PubMed ID: 25435911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH1, SF3B1, MDM2 and MYD88 mutations in patients with chronic lymphocytic leukemia.
    Maleki Y; Alahbakhshi Z; Heidari Z; Moradi MT; Rahimi Z; Yari K; Rahimi Z; Aznab M; Ahmadi-Khajevand M; Bahremand F
    Oncol Lett; 2019 Apr; 17(4):4016-4023. PubMed ID: 30930998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
    Baliakas P; Hadzidimitriou A; Sutton LA; Rossi D; Minga E; Villamor N; Larrayoz M; Kminkova J; Agathangelidis A; Davis Z; Tausch E; Stalika E; Kantorova B; Mansouri L; Scarfò L; Cortese D; Navrkalova V; Rose-Zerilli MJ; Smedby KE; Juliusson G; Anagnostopoulos A; Makris AM; Navarro A; Delgado J; Oscier D; Belessi C; Stilgenbauer S; Ghia P; Pospisilova S; Gaidano G; Campo E; Strefford JC; Stamatopoulos K; Rosenquist R;
    Leukemia; 2015 Feb; 29(2):329-36. PubMed ID: 24943832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation.
    Yu L; Kim HT; Kasar S; Benien P; Du W; Hoang K; Aw A; Tesar B; Improgo R; Fernandes S; Radhakrishnan S; Klitgaard J; Lee C; Getz G; Setlur SR; Brown JR
    Clin Cancer Res; 2017 Feb; 23(3):735-745. PubMed ID: 27503198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
    Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
    Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
    Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
    Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.
    Shuai W; Lin P; Strati P; Patel KP; Routbort MJ; Hu S; Wei P; Khoury JD; You MJ; Loghavi S; Tang Z; Fang H; Thakral B; Medeiros LJ; Wang W
    Blood Cancer J; 2020 Aug; 10(8):86. PubMed ID: 32848129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.
    Schweighofer CD; Coombes KR; Majewski T; Barron LL; Lerner S; Sargent RL; O'Brien S; Ferrajoli A; Wierda WG; Czerniak BA; Medeiros LJ; Keating MJ; Abruzzo LV
    J Mol Diagn; 2013 Mar; 15(2):196-209. PubMed ID: 23273604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
    Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
    Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
    Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
    Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of
    Ahn A; Kim HS; Kim TY; Lee JM; Kang D; Yu H; Lee CY; Kim Y; Eom KS; Kim M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.
    Sadria R; Motamed N; Saberi Anvar M; Mehrabani Yeganeh H; Poopak B
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1757. PubMed ID: 36411516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
    Takahashi K; Hu B; Wang F; Yan Y; Kim E; Vitale C; Patel KP; Strati P; Gumbs C; Little L; Tippen S; Song X; Zhang J; Jain N; Thompson P; Garcia-Manero G; Kantarjian H; Estrov Z; Do KA; Keating M; Burger JA; Wierda WG; Futreal PA; Ferrajoli A
    Blood; 2018 Apr; 131(16):1820-1832. PubMed ID: 29358183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients.
    Eid OM; Abdel Kader RMA; Fathalla LA; Abdelrahman AH; Rabea A; Mahrous R; Eid MM
    J Genet Eng Biotechnol; 2021 Jun; 19(1):98. PubMed ID: 34181122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
    Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
    Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group.
    Roos-Weil D; Nguyen-Khac F; Chevret S; Touzeau C; Roux C; Lejeune J; Cosson A; Mathis S; Feugier P; Leprêtre S; Béné MC; Baron M; Raynaud S; Struski S; Eclache V; Sutton L; Lesty C; Merle-Béral H; Cymbalista F; Ysebaert L; Davi F; Leblond V;
    Genes Chromosomes Cancer; 2018 Nov; 57(11):533-540. PubMed ID: 30203893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV; Saenko V; Bazyka DA
    Probl Radiac Med Radiobiol; 2018 Dec; 23():283-301. PubMed ID: 30582853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.
    Jeromin S; Weissmann S; Haferlach C; Dicker F; Bayer K; Grossmann V; Alpermann T; Roller A; Kohlmann A; Haferlach T; Kern W; Schnittger S
    Leukemia; 2014 Jan; 28(1):108-17. PubMed ID: 24113472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.